Claire Leurent
InvestorManaging Director at AbbVie
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Claire Leurent pairs drug-development experience at Pfizer and Wyeth with cross-institutional venture investing at Samsung, J&J and the NIH, and—while teaching strategy at Northeastern—creates custom deal structures across stages.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
Experience
- AbbVie VenturesManaging Directorcurrent2024 — present
- The National Institutes of HealthEntrepreneur in Residence2023 — 2024Bethesda, Maryland, United States
- Johnson & JohnsonPrincipal, Venture Investments @ JJDC2019 — 2023
- Locus Biosciences, Inc.Board Observer2022
- POINT BiopharmaInvestor2021 — 2022
- PaigeInvestor2021 — 2022New York City Metropolitan Area
- CuraSen Therapeutics, Inc.Board Observer2020 — 2022
- X-Vax Technology, Inc.Board Observer2020 — 2022
- Vor BiopharmaBoard Observer2019 — 2020
- Samsung Venture InvestmentManaging Director2018 — 2019Greater Boston Area
- Samsung Venture InvestmentBio Sector Investment Director - Samsung Ventures America2017 — 2019
- Digital AssetInvestor2019
- Adicet Bio, IncInvestor2019
- WelldocBoard Observer2019
- Pillo HealthBoard Observer2019Boston, Massachusetts
- PfizerDirector - Neuroscience Clinical Research2010 — 2017Cambridge, Massachusetts
- PfizerSenior Clinical Scientist2004 — 2010
- Forenap PharmaProject Manager2003 — 2004
- IGBMC - Institut de Génétique et de Biologie Moléculaire - Strasbourg-Illkirch/FrancePhD1999 — 2003
Education
- MIT Sloan School of ManagementMaster of Business Administration (MBA), Business Administration and Management2014 — 2016
- Pierre and Marie Curie UniversityCertification in CNS Pharmacology2007
- Université Louis Pasteur (Strasbourg I)PhD, Molecular and Cellular Biology1999 — 2003
- Université Louis Pasteur (Strasbourg I)Certification for Investigators in Clinical Trials (DIU FIEC)2001 — 2002
- University of StrasbourgDoctor of Philosophy (PhD), Cell/Cellular and Molecular Biology1999 — 2002
- Centre d'Etudes Internationales de la Propriété Industrielle (CEIPI)2000 — 2001
Skills & more
Neuroscience99Pharmaceutical Industry99Clinical Research99Life Sciences98Biotechnology83Clinical Development82Drug Development74Clinical Trials63Drug Discovery51Pharmacology34Molecular Biology29Lifesciences24
+12 more
GCPOncologyRegulatory AffairsBusiness DevelopmentRegulatory SubmissionsTherapeutic AreasImmunologyFDANeurologyMentoringINDVaccinesFrom Claire's professional profile.
Colleagues at AbbVie
Anke Reichardt
Investor at AbbVie
Anthony Melendez
Managing Director at AbbVie
Christian Schubert
Head of AbbVie Ventures at AbbVie
Christina Vorvis
Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie
John Gustofson
Managing Director at AbbVie
Frequently asked questions
- Where does Claire Leurent work?
- Claire Leurent is Managing Director at AbbVie.
- What does Claire Leurent invest in?
- Claire Leurent invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
- What check size does Claire Leurent write?
- Claire Leurent typically writes checks of $100K – $5M.
Same school
Also attended MIT Sloan School of Management489
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 483 more
Also attended Pierre and Marie Curie University48
Jeff ClavierFounding Partner at Uncork CapitalJean SiniGeneral Partner at Partech VenturesDimitri KrempPrincipal at Axeleo CapitalJack GuedjInvestor at Sand Hill AngelsOphélie LaurinInvestment Associate at World FundRémi DrollerManaging Partner at Kurma Partners
+ 42 more
Also attended University of Strasbourg19
Steven BohnFinancial Controller at Partech VenturesGrégoire KairysCompliance & Internal Control at Iris CapitalPierre SochaPartner at Amadeus Capital PartnersHansjörg SagePartner at LeadX Capital PartnersAnya BerezhnaInvestor at Bamboo Capital PartnersAmel TounsiInvestment Manager at Meusinvest (Noshaq)
+ 13 more
